Blood of the Unborn

A high-ranking FSB official has long been overseeing the important work of producing a very unusual medicine that sustains strength, health, and prolongs youth. Demand creates supply: production of the drug must be increased. And there is money—big money; there are proven technologies; there are interested parties. Only raw material is missing—an unusual one: embryos of 25-week unborn babies.